Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 33 min ago
Peer-reviewedLicence not statedPsychopharmacology Bulletin

Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research

Related

  1. Canine-Assisted Interventions and Symptoms Associated with Borderline Personality Disorder: A Scoping Review
    Emma Pestell, Richard Gorman
    PsyArXivPreprintAll rights reservedFull textPsychiatry & mental healthOSF
  2. Machine Learning in the Differential Diagnosis of Bipolar and Borderline Personality Disorders: A Scoping Review
    Aroldo Dargél, Tanya Tanya, Asma Alhadhrami +5
    Canadian Journal of Psychiatry. Revue Canadienne de PsychiatriePeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
  3. Borderline personality disorder, a diagnosis that cannot be challenged: If rejecting the diagnosis is a symptom, can the diagnosis ever be wrong? A response to Chazhoor and Younger (2026)
    Laurence Cobbaert
    PsyArXivPreprintCC BY 4.0Full textPsychiatry & mental healthOSF
  4. Association of Borderline Personality Traits and Impulsivity with Problem Gambling Severity in Gambling Disorder
    Esma Çörekli Kaymakçı, Cansu Ünsal Mavi, Yusuf Benli +1
    Psikiyatride Güncel YaklaşımlarPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthDOAJ
  5. Sociodemographic and clinical predictors in patients with borderline personality disorder: A 12-month follow-up study
    Andrea Aguglia, Gabriele Sapia, Francesco Stefanini +8
    CNS SpectrumsPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
BibTeX
@article{lazzari2026piloting,
  title = {{Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research}},
  author = {Carlo Lazzari and Marco Rabottini},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  month = oct,
  doi = {10.64719/pb.21597},
  url = {https://doi.org/10.64719/pb.21597},
}
RIS
TY  - JOUR
TI  - Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research
AU  - Carlo Lazzari
AU  - Marco Rabottini
PY  - 2026
DA  - 2026/10/30
JO  - Psychopharmacology Bulletin
DO  - 10.64719/pb.21597
UR  - https://doi.org/10.64719/pb.21597
SN  - 0048-5764
SN  - 2472-2448
ER  -